Literature DB >> 28474553

Metal Complex-Peptide Conjugates: How to Modulate Bioactivity of Metal-Containing Compounds by the Attachment to Peptides.

Ines Neundorf1.   

Abstract

During the last years, the interest in combining the features of metal-containing molecules with biomolecules, particularly peptides, has been increased. Large series of new innovative organometallic compounds, as well as potent coordination complexes have been designed and, especially in medicinal chemistry, the library of bioactive compounds was excessively expanded by the introduction of metal complexes. The research foci are divers and not limited to e.g. the development of therapeutics with anti-proliferative or antibacterial activity, or the design of novel biosensors useful for pharmaceutical applications. By introduction of a metal centre, new attributes might be added that could help to overcome the problems of difficult to treat diseases, as well as to combat issues with arising drug resistances. However, the application of a number of very potent metal complexes is restricted owing to their poor water-solubility, air-stability and only poor uptake when in contact with cells. In this context, one possibility to optimize promising lead structures is to couple them to bioactive peptides. Within this review, an overview on metal complex-peptide conjugates used for drug design and future pharmaceutical application is presented. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cell-penetrating peptides; anti-cancer therapy; antimicrobial peptides; biosensor; organometallic complexes; solid phase peptide synthesis

Mesh:

Substances:

Year:  2017        PMID: 28474553     DOI: 10.2174/0929867324666170505112836

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  1 in total

1.  Building up PtII -Thiosemicarbazone-Lysine-sC18 Conjugates.

Authors:  Alexander Haseloer; Tamara Lützenburg; Joss Pepe Strache; Jörg Neudörfl; Ines Neundorf; Axel Klein
Journal:  Chembiochem       Date:  2020-11-06       Impact factor: 3.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.